Skip to main contentU.S. National Library of MedicineU.S. National Library of Medicine

Profiles in Science
Pinterest badge Follow Profiles in Science on Pinterest!

The Mary Lasker Papers

Letter from Samuel Broder to Mary Lasker pdf (66,672 Bytes) transcript of pdf
Letter from Samuel Broder to Mary Lasker
Samuel Broder, director of the National Cancer Institute in the late 1980s, stated that Lasker "has meant essentially everything . . . to the . . . National Institutes of Health. She is a genius who forced the realization that the federal government must commit itself to medical research to benefit all Americans."
Number of Image Pages:
1 (66,672 Bytes)
1990-08-27 (August 27, 1990)
Broder, Samuel
National Cancer Institute (U.S.)
Lasker, Mary
Original Repository: Columbia University. Rare Book and Manuscript Library. Mary Lasker Papers
This item is in the public domain. It may be used without permission.
Medical Subject Headings (MeSH):
Cancer Vaccines
Exhibit Category:
Cancer Wars
Box Number:
Unique Identifier:
Document Type:
Letters (correspondence)
Physical Condition:
Series: Series I
SubSeries: Topical Files
SubSubSeries: Cancer
Folder: Cancer Vaccine Workshop, NCI, 29-30 October 1990
August 27, 1990
Dear Mrs. Lasker:
This letter is to invite you to attend and participate in a workshop on cancer vaccines being sponsored by the National Cancer Institute, to be held October 29-30, 1990 at the Hyatt Regency Hotel in Bethesda, Maryland.
Vaccination is a classical technique to prevent infectious disease. It has been used successfully against a variety of bacterial and viral diseases. It is important that we now give serious consideration to the utilization of a vaccine approach for cancer prevention and control.
Recent advances in molecular biology and immunology, as well as recent results with tumor vaccines in some clinical trials and in preclinical animal tumor models, provide a strong impetus for focusing efforts and resources on vaccines as an important new approach to the prevention and treatment of cancer. Such cancer vaccines would be aimed at preventing the recurrence and metastatic spread of cancer in patients diagnosed with a primary tumor, and at preventing the development of cancer in individuals at high risk for malignant disease. At this meeting, a number of scientific experts will provide the most up-to-date information on topics such as viral vaccines, tumor antigens as vaccine targets, stimulation of activated cells, and prospects for cancer vaccine development. In addition, participants will be encouraged to suggest fruitful areas for future investigation, as well as necessary resources to support these investigations.
Because of your interest in and support for cancer research, I wanted to bring this important meeting to your attention, and to invite you to attend and participate. You will receive an accompanying letter from Dr. Jack Gruber, Chief of NCI's Biological Carcinogenesis Branch, which will provide details of the meeting arrangements. I hope you can reserve October 29 and 30 for this purpose, and I look forward to seeing you there.
Sincerely yours,
Samuel Broder, M.D.
National Cancer Institute
Metadata Last Modified Date:
Linked Data:
RDF/XML     JSON     JSON-LD     N3/Turtle     N-Triples